SEC 13F Intelligence

Natixis Advisors, LLC / CVS

Natixis Advisors, LLC’s Cvs Health Corp Position

Does Natixis Advisors, LLC own Cvs Health Corp (CVS)? Yes — 1.39M shares worth $100M (+0.14% of its 13F portfolio) as of Q1 2026, up from 1.28M shares the prior filed quarter.

Position Value
$100M
Q1 2026
Shares
1.39M
% of Portfolio
+0.14%
Quarters Held
30
currently held

Position History CVS

Reported value by quarter
Q4 ’18: $22MQ4 ’18Q1 ’19: $12MQ2 ’19: $19MQ3 ’19: $27MQ4 ’19: $34MQ4 ’19Q1 ’20: $29MQ2 ’20: $32MQ3 ’20: $26MQ4 ’20: $31MQ4 ’20Q1 ’21: $36MQ2 ’21: $41MQ3 ’21: $44MQ4 ’21: $59MQ4 ’21Q1 ’22: $59MQ2 ’22: $51MQ3 ’22: $66MQ4 ’22: $53MQ4 ’22Q1 ’23: $36MQ2 ’23: $25MQ3 ’23: $35MQ4 ’23: $52MQ4 ’23Q1 ’24: $60MQ2 ’24: $40MQ3 ’24: $53MQ4 ’24: $25MQ4 ’24Q1 ’25: $74MQ2 ’25: $86MQ3 ’25: $101MQ4 ’25: $101MQ4 ’25Q1 ’26: $100Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.39M$100M+0.14%
Q4 20251.28M$101M+0.14%
Q3 20251.33M$101M+0.15%
Q2 20251.24M$86M+0.14%
Q1 20251.09M$74M+0.14%
Q4 2024565.2K$25M+0.05%
Q3 2024846.2K$53M+0.10%
Q2 2024675.6K$40M+0.09%
Q1 2024750.3K$60M+0.14%
Q4 2023661.8K$52M+0.14%
Q3 2023507.3K$35M+0.11%
Q2 2023368.3K$25M+0.08%
Q1 2023477.9K$36M+0.12%
Q4 2022565.5K$53M+0.20%
Q3 2022695.8K$66M+0.28%
Q2 2022550.4K$51M+0.22%
Q1 2022584.4K$59M+0.23%
Q4 2021570.2K$59M+0.22%
Q3 2021523.3K$44M+0.18%
Q2 2021490.1K$41M+0.19%
Q1 2021472.0K$36M+0.19%
Q4 2020448.7K$31M+0.18%
Q3 2020446.2K$26M+0.16%
Q2 2020485.8K$32M+0.21%
Q1 2020494.5K$29M+0.24%
Q4 2019459.2K$34M+0.24%
Q3 2019430.5K$27M+0.22%
Q2 2019354.6K$19M+0.16%
Q1 2019223.9K$12M+0.11%
Q4 2018336.2K$22M+0.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of CVS.